2015
DOI: 10.15761/cogrm.1000103
|View full text |Cite
|
Sign up to set email alerts
|

Management of gestational trophoblastic neoplasia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 38 publications
(60 reference statements)
0
1
0
Order By: Relevance
“…The work of Agarval et al concerns the validation of the uterine artery pulsatility index (UAPI, a measure of tumour vascularity) as a useful indicator for predicting resistance to MTX chemotherapy [288]. A similar issue is also the subject of the works of Secki et al [289] and Hussain et al [290]. Stratification of patients of lowor high-risk GTN for single-agent chemotherapy (with MTX-LV or ACT) or multi-agents chemotherapy, respectively, is based on the assessment of the CXH and FIGO indexes.…”
Section: Methotrexate-based Therapy Of Gestational Trophoblastic Diseasementioning
confidence: 99%
“…The work of Agarval et al concerns the validation of the uterine artery pulsatility index (UAPI, a measure of tumour vascularity) as a useful indicator for predicting resistance to MTX chemotherapy [288]. A similar issue is also the subject of the works of Secki et al [289] and Hussain et al [290]. Stratification of patients of lowor high-risk GTN for single-agent chemotherapy (with MTX-LV or ACT) or multi-agents chemotherapy, respectively, is based on the assessment of the CXH and FIGO indexes.…”
Section: Methotrexate-based Therapy Of Gestational Trophoblastic Diseasementioning
confidence: 99%